Granzyme B PET Imaging Stratifies Immune Checkpoint Inhibitor Response in Hepatocellular Carcinoma
Hepatocellular carcinoma (HCC) is a notoriously difficult cancer to treat. The recent development of immune checkpoint inhibitors has revolutionised HCC therapy; however, successful response is only observed in a small percentage of patients. Biomarkers typically used to predict treatment response i...
Saved in:
Main Authors: | Julian L. Goggi, Boominathan Ramasamy, Yun Xuan Tan, Siddesh V. Hartimath, Jun Rong Tang, Peter Cheng, Rasha Msallam, Ann-Marie Chacko, You Yi Hwang, Edward G. Robins |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2021-01-01
|
Series: | Molecular Imaging |
Online Access: | http://dx.doi.org/10.1155/2021/9305277 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Immunity revealed: Stratifying hepatocellular carcinoma for precision immunotherapy
by: Konstantinos Arvanitakis, et al.
Published: (2025-03-01) -
Expression and Function of Granzymes A and B in Escherichia coli Peritonitis and Sepsis
by: M. Isabel García-Laorden, et al.
Published: (2017-01-01) -
Development of chimeric Nanobody-Granzyme B functionalized ferritin nanoparticles for precise tumor therapy
by: Baijin Xia, et al.
Published: (2025-03-01) -
Imaging Hepatocellular Carcinoma With Ga-Citrate PET: First Clinical Experience
by: Carina Mari Aparici MD, et al.
Published: (2017-09-01) -
Heterogeneity in polyamine metabolism dictates prognosis and immune checkpoint blockade response in hepatocellular carcinoma
by: Jianyan Pan, et al.
Published: (2025-02-01)